Benetech

BenetechBenetech
Benetech

Benetech

Benetech is a nonprofit social enterprise organization that empowers communities with software for social good. Previous projects include the Route 66 Literacy

DR 711997Active75Palo Alto, United States
Rate

About

Benetech is a nonprofit dedicated to accessible education, empowering learners who read differently through its core product, Bookshare, the world's largest library of accessible ebooks. They also offer Bookshare+ for AI-powered tutoring and document accessibility, and BASE services to help educational institutions achieve inclusive education and compliance. Benetech serves students, educators, and institutions across the US and globally, aiming to break down barriers to learning.
Frequently asked

What does Benetech do?

Benetech is a nonprofit dedicated to accessible education, empowering learners who read differently through its core product, Bookshare, the world's largest library of accessible ebooks. They also offer Bookshare+ for AI-powered tutoring and document accessibility, and BASE services to help educational institutions achieve inclusive education and compliance. Benetech serves students, educators, and institutions across the US and globally, aiming to break down barriers to learning.

What is Benetech's valuation?

StartupHub estimates Benetech's effective valuation at $39.4M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Benetech raised?

Benetech has raised a total of $10M in funding. The most recent round on record is Grant.

Where is Benetech headquartered?

Benetech is headquartered in Palo Alto, United States.

When was Benetech founded?

Benetech was founded in 1997.

What industry does Benetech operate in?

Benetech operates in Social Good, Human Rights, Environmental Sustainability, Disaster Response, Nonprofit Technology, Open Source Software.

How many employees does Benetech have?

Benetech has approximately 75 people on record.

HEADCOUNT
75
DOMAIN RATING
71
Comments

No comments yet. Be the first to share your take.